All you need is the One System Solution
For All Arrhythmias and Ablations
The right system for your procedures is the one that allows you to treat AFib your way for optimal outcomes, safety and efficiency.
Abbott gives you more opportunities to choose the course of treatment and workflow that's right for your patients. EnSiteTM X EP System, The Industry’s Only Open Architecture Design, is the only system to offer a comprehensive solution for RF and PFA procedures - from mapping to outcomes.
Improve Procedural Success Rates for All AF Types. Map Beyond PVI.
EnSite™ X EP System provides the mapping flexibility, detail and real-time technology vital for low-voltage area ablation procedures.
Map beyond PVI to identify, target and ablate cardiac tissue with specificity for acute and long-term outcomes. Patients undergoing 3D mapping-guided low-voltage area are experiencing greater freedom from paroxysmal and persistent AF.
Significantly Reduce Atrial Tachyarrhythmia Recurrence with 3D Mapping-Guided Low-Voltage Area Therapy1
Adjunct 3D mapping-guided low-voltage area ablation is proven effective and safe for patients undergoing AF ablation.
Fewer atrial tachyarrhythmia recurrences1
Lower number of redo ablation procedures1
Fewer atrial tachyarrhythmia recurrences1
Reduce Atrial Arrhythmia Recurrence Rates and Avoid OverAblation3
15%
lower rate of recurrence for patients with persistent AF undergoing PVI with substrate modification vs PVI only (35% vs. 50%)3
Specifically targeting ablation to truly diseased myocardium using voltage maps helps to create dedicated lesions that spare healthy tissue3
Improve Long-Term Outcomes in Older Patients with Paroxysmal AF2
39%
decrease in atrial tachyarrhythmia recurrence risk with mapping-guided low-voltage area ablation beyond circumferential PVI (CPVI) vs. CPVI alone2
2 - 3
year improved outcomes; differentiation in patient populations noted at 1 year2
Tailor Ablation Strategies to Promote Better Acute and Long-Term Clinical Outcomes for Persistent AF4
Patient Undergoing Circumferential PV Ablation4:
50%
13%
Improved acute intraprocedural arrhythmia termination4
Higher procedural success rates4
Create Efficiencies. Map to Optimize Workflow.
One System Solution: the only open architecture design that gives you full flexibility to treat AFib your way.
1. Create Geometry From Any Catheter You Choose
Seamlessly transition between impedance and magnetic based mapping throughout your case on our 2-in-1 system with EnSite™ VoXel Flex Mode.
2. Navigate and Ablate in All Modalities
Perform high-power RF ablation with safety, stability and efficiency with the TactiFlex™ Ablation Catheter, Sensor Enabled™ – the first and only contact force catheter with a flexible tip.
Visualize catheter position with outstanding image quality using ICE-guided ablation during PFA ablation with ViewFlex™ Xtra ICE Catheter and ViewMate™ Multi Ultrasound System.
3. Map Complex Arrhythmias With Unique Software Solutions
Simply, objectively and automatically assess near field signals by isolating true, localized signals with the automated point annotation of EnSite™ OT Near Field software.
Increase workflow efficiency and tailor treatment to individual cases through 3rd party system integration with EnSite™ LiveSync Module.
Efficient
Get in and out of your lab faster with software and hardware designed for efficiency.
- Reduce the number of connections by up to 50%† to facilitate a faster, easier system setup
- 94% of operators saw improved system usability with an optimized software user interface5
- 93% of users agreed the new system setup allows for faster troubleshooting and minimized downtime5
A System Built to Last
- Next generation platform with annual software release cadence
- Enhanced cybersecurity capabilities including access restrictions, white listing and strengthened patient data protection
† Reduction of connections from the patient connecting to the amplifier from 55 (EnSite Precision™ Cardiac Mapping System) to 25 (EnSite™ X EP System) for an AF case.
References
- Rivera, A. et al. (2024). Adjunctive Low-voltage area ablation for patients with atrial fibrillation: An updated meta-analysis of Randomized Controlled Trials. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/jce.16290.
- Chen, H. et al. (2023). Circumferential pulmonary vein isolation with vs without additional low-voltage-area ablation in older patients with paroxysmal atrial fibrillation. JAMA Cardiology, 8(8), 765. https://doi.org/10.1001/jamacardio.2023.1749.
- Huo, Y. et al. (2022). Low-voltage myocardium-guided ablation trial of persistent atrial fibrillation. NEJM Evidence, 1(11). https://doi.org/10.1056/evidoa2200141.
- Pappone, C. et al. (2018). Clinical outcome of electrophysiologically guided ablation for nonparoxysmal atrial fibrillation using a novel real-time 3-dimensional mapping technique. Circulation: Arrhythmia and Electrophysiology, 11(3). https://doi.org/10.1161/circep.117.005904.
- Abbott. Data on File. Document #90471779.
MAT-2109938 v4.0